Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16


Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.

Phillips AN, Carr A, Neuhaus J, Visnegarwala F, Prineas R, Burman WJ, Williams I, Drummond F, Duprez D, Belloso WH, Goebel FD, Grund B, Hatzakis A, Vera J, Lundgren JD.

Antivir Ther. 2008;13(2):177-87.


Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.

Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V.

PLoS Med. 2008 Apr 8;5(4):e78. doi: 10.1371/journal.pmed.0050078. Review.


Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292.


HLA-B*5701 screening for hypersensitivity to abacavir.

Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A; PREDICT-1 Study Team.

N Engl J Med. 2008 Feb 7;358(6):568-79. doi: 10.1056/NEJMoa0706135.


Asymptomatic myocardial ischaemia in HIV-infected adults.

Carr A, Grund B, Neuhaus J, El-Sadr WM, Grandits G, Gibert C, Prineas RJ; SMART Study Investigators.

AIDS. 2008 Jan 11;22(2):257-67.


Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study.

Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sørensen HT, Gerstoft J.

Clin Infect Dis. 2007 Jun 15;44(12):1625-31. Epub 2007 May 10.


Class of antiretroviral drugs and the risk of myocardial infarction.

DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.

N Engl J Med. 2007 Apr 26;356(17):1723-35.


Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

Triant VA, Lee H, Hadigan C, Grinspoon SK.

J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12. Epub 2007 Apr 24.


CD4+ count-guided interruption of antiretroviral treatment.

Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fätkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C.

N Engl J Med. 2006 Nov 30;355(22):2283-96.


Inflammation, atherosclerosis, and coronary artery disease.

Hansson GK.

N Engl J Med. 2005 Apr 21;352(16):1685-95. Review. No abstract available.


Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.

Iloeje UH, Yuan Y, L'italien G, Mauskopf J, Holmberg SD, Moorman AC, Wood KC, Moore RD.

HIV Med. 2005 Jan;6(1):37-44.


Combination antiretroviral therapy and the risk of myocardial infarction.

Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group.

N Engl J Med. 2003 Nov 20;349(21):1993-2003. Erratum in: N Engl J Med. 2004 Feb 26;350(9):955.


Coronary heart disease in HIV-infected individuals.

Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S.

J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):506-12.


Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6.

Woods A, Brull DJ, Humphries SE, Montgomery HE.

Eur Heart J. 2000 Oct;21(19):1574-83. Review. No abstract available.


Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism.

Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E.

Thromb Haemost. 1994 Aug;72(2):302-8.


Supplemental Content

Support Center